Hepatorenal syndrome in cirrhotic patients: Terlipressine is a safe and efficient treatment; Propranolol and digitalic treatments: Precipitating and preventing factors?

被引:27
作者
Duhamel, C [1 ]
Mauillon, J [1 ]
Berkelmans, I [1 ]
Bourienne, A [1 ]
Tranvouez, JL [1 ]
机构
[1] Le Havre Hosp, Hepatogastroenterol Unit, F-76600 Le Havre, France
关键词
D O I
10.1016/S0002-9270(00)02007-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:2984 / 2985
页数:2
相关论文
共 7 条
[1]   Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [J].
Arroyo, V ;
Gines, P ;
Gerbes, AL ;
Dudley, FJ ;
Gentilini, P ;
Laffi, G ;
Reynolds, TB ;
RingLarsen, H ;
Scholmerich, J .
HEPATOLOGY, 1996, 23 (01) :164-176
[2]  
BONNARD P, 1998, GASTROENTEROLOGY, V114, P1214
[3]  
CERVONI JP, 1997, AM J GASTROENTEROL, V92, P211
[4]  
DUHAMEL C, 1999, GUT S5, V45, pA217
[5]   Hepatorenal syndrome - Long-term treatment with terlipressin as a bridge to liver transplantation [J].
GanneCarrie, N ;
Hadengue, A ;
Mathurin, P ;
Durand, F ;
Erlinger, S ;
Benhamou, JP .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (06) :1054-1056
[6]   Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome [J].
Hadengue, A ;
Gadano, A ;
Moreau, R ;
Giostra, E ;
Durand, F ;
Valla, D ;
Erlinger, S ;
Lebrec, D .
JOURNAL OF HEPATOLOGY, 1998, 29 (04) :565-570
[7]  
Le Moine O, 1998, ACTA GASTRO-ENT BELG, V61, P268